{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:06Z","timestamp":1792636686309,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clear cell sarcoma and gastrointestinal neuroectodermal tumor are ultra-rare soft tissue sarcomas with no established standard of care for advanced disease. Data evaluating outcomes of systemic therapy remain limited. We aimed to evaluate systemic therapy in patients with metastatic clear cell sarcoma and gastrointestinal neuroectodermal tumor treated at a tertiary referral institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective, single-institution study of patients with metastatic clear cell sarcoma and gastrointestinal neuroectodermal tumor diagnosed between January 2000 and May 2025. The primary objective was to describe patterns of systemic therapy use, and secondary endpoints included overall survival (OS) and real-world progression-free survival (PFS). Survival outcomes were estimated using the Kaplan\u2013Meier method. Hazard ratios were estimated using Cox proportional hazards models. Exploratory analyses evaluated outcomes by treatment class.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 66 patients were included; 55 received systemic therapy. Median follow-up was 192\u2009months, and patients received a median of 2 treatment lines with heterogeneous sequencing. Median OS was 18\u2009months (95% CI = 13.6 to 28.0). In first-line analyses, tyrosine kinase inhibitor\u2013based therapy and immune checkpoint inhibitors were associated with improved OS compared with doxorubicin-based chemotherapy (tyrosine kinase inhibitor: hazard ratio [HR]\u2009=\u20090.33, 95% CI = 0.14 to 0.79; P\u2009=\u2009.01; immune checkpoint inhibitor: HR = 0.39, 95% CI = 0.10 to 0.94; P\u2009=\u2009.04). Median first-line real-world PFS was 3.8\u2009months (95% CI = 2.9 to 6.3), with no statistically significant differences between treatment classes. Nondoxorubicin\u2013based chemotherapy was associated with shorter real-world PFS compared with doxorubicin regimens (HR = 4.1, 95% CI = 1.71 to 9.83; P\u2009&amp;lt;\u2009.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metastatic clear cell sarcoma and gastrointestinal neuroectodermal tumor is highly aggressive with limited effective systemic options. Outcomes remain poor, highlighting the need for novel therapies and collaborative studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jncics\/pkag096","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:25:34Z","timestamp":1789755934000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment patterns and outcomes in advanced clear cell sarcoma and gastrointestinal neuroectodermal tumors"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0043-8374","authenticated-orcid":false,"given":"Adel","family":"Shahnam","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-9032","authenticated-orcid":false,"given":"Daniel","family":"Reinhorn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-0119","authenticated-orcid":false,"given":"Mrinal M","family":"Gounder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoena","family":"Desir-Camille","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7222-781X","authenticated-orcid":false,"given":"Olayode","family":"Babatunde","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara M","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B","family":"Banks","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2591-7187","authenticated-orcid":false,"given":"Viswatej","family":"Avutu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-6606","authenticated-orcid":false,"given":"Sujana","family":"Movva","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon R","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8240-4900","authenticated-orcid":false,"given":"Mary L","family":"Keohan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-8205","authenticated-orcid":false,"given":"Cristina R","family":"Antonescu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-652X","authenticated-orcid":false,"given":"Konstantinos","family":"Linos","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-2310","authenticated-orcid":false,"given":"Narasimhan","family":"Agaram","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]},{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9853-2528","authenticated-orcid":false,"given":"Robert G","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra P","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-2796","authenticated-orcid":false,"given":"William D","family":"Tap","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,","place":["United States"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2026102121420548600_pkag096-B1","author":"WHO Classification of Tumours Editorial Boar: Soft Tissue and Bone Tumours WHO","year":"2020"},{"key":"2026102121420548600_pkag096-B2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/jcm14041233","article-title":"Clear Cell Sarcoma (CCS) of the soft tissue: an update narrative review with emphasis on the utility of PRAME in differential diagnosis","volume":"14","author":"Cazzato","year":"2025","journal-title":"J Clin Med"},{"key":"2026102121420548600_pkag096-B3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00428-020-02933-2","article-title":"Clear cell sarcoma-like\/malignant gastrointestinal neuroectodermal tumor of the tongue: a clinicopathologic and molecular case report","volume":"478","author":"Sbaraglia","year":"2021","journal-title":"Virchows Arch"},{"key":"2026102121420548600_pkag096-B4","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1158\/1078-0432.CCR-05-2811","article-title":"EWS-CREB1: a recurrent variant fusion in clear cell sarcoma\u2014association with gastrointestinal location and absence of melanocytic differentiation","volume":"12","author":"Antonescu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2026102121420548600_pkag096-B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5858\/arpa.2013-0547-RS","article-title":"Clear cell sarcoma-like tumor of the gastrointestinal tract: an evolving entity","volume":"139","author":"Wang","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2026102121420548600_pkag096-B6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/PAS.0000000000001396","article-title":"Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, Immunohistochemical, and molecular analysis of 19 cases","volume":"44","author":"Chang","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"2026102121420548600_pkag096-B7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.pathol.2018.05.001","article-title":"Clear cell sarcoma of the gastrointestinal tract and malignant gastrointestinal neuroectodermal tumour: distinct or related entities? A review","volume":"50","author":"Green","year":"2018","journal-title":"Pathology"},{"key":"2026102121420548600_pkag096-B8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/jjco\/hyad083","article-title":"The current management of clear cell sarcoma","volume":"53","author":"Ikuta","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"2026102121420548600_pkag096-B9","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.esmoop.2022.100522","article-title":"Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network","volume":"7","author":"Smrke","year":"2022","journal-title":"ESMO Open"},{"key":"2026102121420548600_pkag096-B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/cancers18040641","article-title":"Clear cell and histiocytic\/dendritic cell sarcomas: clinical outcomes, molecular features, and diagnostic pitfalls","volume":"18","author":"Tinoco","year":"2026","journal-title":"Cancers"},{"key":"2026102121420548600_pkag096-B11","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.2147\/CMAR.S337253","article-title":"Clinical experience with apatinib and camrelizumab in advance clear cell sarcoma: a retrospective study","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"2026102121420548600_pkag096-B12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/1120009X.2024.2372524","article-title":"Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy","volume":"37","author":"Czarnecka","year":"2025","journal-title":"J Chemother"},{"key":"2026102121420548600_pkag096-B13","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1002\/cncr.35483","article-title":"Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial\/NCCH1510)","volume":"130","author":"Nishikawa","year":"2024","journal-title":"Cancer"},{"key":"2026102121420548600_pkag096-B14","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1093\/annonc\/mdx527","article-title":"Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European organization for research and treatment of cancer phase II trial 90101 \u201cCREATE","volume":"28","author":"Sch\u00f6ffski","year":"2017","journal-title":"Ann Oncol"},{"key":"2026102121420548600_pkag096-B15","doi-asserted-by":"publisher","first-page":"0015","DOI":"10.34133\/cancomm.0015","article-title":"IMMUNOSARC II master trial: phase II study of sunitinib and nivolumab in clear cell sarcoma cohort","volume":"46","author":"Martin-Broto","year":"2026","journal-title":"Cancer Commun (Lond)"},{"key":"2026102121420548600_pkag096-B16","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00432-018-2693-6","article-title":"The epidemiology and survivorship of clear cell sarcoma: a National Cancer Database (NCDB) review","volume":"144","author":"Gonzaga","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026102121420548600_pkag096-B17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s13193-024-02108-4","article-title":"Surgically treated clear cell sarcomas\u2013what influences outcomes?","volume":"16","author":"Tadala","year":"2025","journal-title":"Indian J Surg Oncol"},{"key":"2026102121420548600_pkag096-B18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1302\/0301-620X.105B11.BJJ-2022-0743.R3","article-title":"Factors associated with survival in patients with clear cell sarcoma","volume":"105-B","author":"Fujiwara","year":"2023","journal-title":"Bone Joint J"},{"key":"2026102121420548600_pkag096-B19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1158\/0008-5472.CAN-09-1121","article-title":"Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma","volume":"70","author":"Davis","year":"2010","journal-title":"Cancer Res"},{"key":"2026102121420548600_pkag096-B20","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.12659\/MSM.916705","article-title":"Prognostic factors for survival in patients with clear cell sarcoma: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database","volume":"25","author":"Li","year":"2019","journal-title":"Med Sci Monit"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkag096\/71353944\/pkag096.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/5\/pkag096\/71353944\/pkag096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/10\/5\/pkag096\/71353944\/pkag096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:42:14Z","timestamp":1792633334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkag096\/8832350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkag096","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"pkag096"}}